157 related articles for article (PubMed ID: 14696007)
1. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
Southworth R; Parry CR; Parkes HG; Medina RA; Garlick PB
NMR Biomed; 2003 Dec; 16(8):494-502. PubMed ID: 14696007
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat.
Paans AM; Pruim J
NMR Biomed; 2004 Jun; 17(4):206-7; author reply 208. PubMed ID: 15229933
[No Abstract] [Full Text] [Related]
3. Noninvasive in vivo demonstration of 2-fluoro-2-deoxy-D-glucose metabolism beyond the hexokinase reaction in rat brain by 19F nuclear magnetic resonance spectroscopy.
Nakada T; Kwee IL; Conboy CB
J Neurochem; 1986 Jan; 46(1):198-201. PubMed ID: 3940280
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
Southworth R; Dearling JL; Medina RA; Flynn AA; Pedley RB; Garlick PB
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1334-41. PubMed ID: 12271416
[TBL] [Abstract][Full Text] [Related]
5. Mapping phosphorylation rate of fluoro-deoxy-glucose in rat brain by (19)F chemical shift imaging.
Coman D; Sanganahalli BG; Cheng D; McCarthy T; Rothman DL; Hyder F
Magn Reson Imaging; 2014 May; 32(4):305-13. PubMed ID: 24581725
[TBL] [Abstract][Full Text] [Related]
6. [Uptake of FDG (2-fluoro-2-deoxy-D-glucose) as a tumor imaging agent into erythrocytes and accumulation of FDG in tumor cells].
Minosako Y; Nemoto M; Ino S; Shirakami Y; Kurami M
Kaku Igaku; 2003 Feb; 40(1):23-30. PubMed ID: 12701204
[TBL] [Abstract][Full Text] [Related]
7. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
Hariharan R; Bray M; Ganim R; Doenst T; Goodwin GW; Taegtmeyer H
Circulation; 1995 May; 91(9):2435-44. PubMed ID: 7729031
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate.
Kanazawa Y; Yamane H; Shinohara S; Kuribayashi S; Momozono Y; Yamato Y; Kojima M; Masuda K
J Neurochem; 1996 May; 66(5):2113-20. PubMed ID: 8780043
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR.
Kanazawa Y; Momozono Y; Ishikawa M; Yamada T; Yamane H; Haradahira T; Maeda M; Kojima M
Life Sci; 1986 Aug; 39(8):737-42. PubMed ID: 3736344
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-19 NMR imaging of glucose metabolism.
Nakada T; Kwee IL; Card PJ; Matwiyoff NA; Griffey BV; Griffey RH
Magn Reson Med; 1988 Mar; 6(3):307-13. PubMed ID: 3362066
[TBL] [Abstract][Full Text] [Related]
12. Differential uptake of FDG and DG during post-ischaemic reperfusion in the isolated, perfused rat heart.
Garlick PB; Medina RA; Southworth R; Marsden PK
Eur J Nucl Med; 1999 Oct; 26(10):1353-8. PubMed ID: 10541837
[TBL] [Abstract][Full Text] [Related]
13. Temporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucose.
Nguyêñ VT; Mossberg KA; Tewson TJ; Wong WH; Rowe RW; Coleman GM; Taegtmeyer H
Am J Physiol; 1990 Oct; 259(4 Pt 2):H1022-31. PubMed ID: 2221110
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of energy metabolism in brain using epimerization of 2-deoxy-2-fluoro-D-glucose by 19F NMR: the effect of anesthesia.
Shinohara S; Kanazawa Y; Kojima M
Magn Reson Med; 1991 Oct; 21(2):191-6. PubMed ID: 1745118
[TBL] [Abstract][Full Text] [Related]
15. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging.
Kanazawa Y; Umayahara K; Shimmura T; Yamashita T
NMR Biomed; 1997 Jan; 10(1):35-41. PubMed ID: 9251114
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice.
Sala-Rabanal M; Hirayama BA; Ghezzi C; Liu J; Huang SC; Kepe V; Koepsell H; Yu A; Powell DR; Thorens B; Wright EM; Barrio JR
J Physiol; 2016 Aug; 594(15):4425-38. PubMed ID: 27018980
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of cerebral glucose metabolic rates after blood-brain barrier disruption induced by focused ultrasound using FDG-MicroPET.
Yang FY; Chang WY; Chen JC; Lee LC; Hung YS
Neuroimage; 2014 Apr; 90():93-8. PubMed ID: 24368263
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive demonstration of in vivo 3-fluoro-3-deoxy-D-glucose metabolism in rat brain by 19F nuclear magnetic resonance spectroscopy: suitable probe for monitoring cerebral aldose reductase activities.
Kwee IL; Nakada T; Card PJ
J Neurochem; 1987 Aug; 49(2):428-33. PubMed ID: 3110372
[TBL] [Abstract][Full Text] [Related]
19. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectroscopy.
Pouremad R; Wyrwicz AM
NMR Biomed; 1991 Aug; 4(4):161-6. PubMed ID: 1931555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
